Page last updated: 2024-10-16

allantoin and Libman-Sacks Disease

allantoin has been researched along with Libman-Sacks Disease in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Patients with systemic lupus erythematosus (SLE) experience excess morbidity and mortality due to coronary artery disease (CAD) that cannot be fully explained by the classical CAD risk factors."2.71Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. ( Benzie, IF; Griffith, JF; Lee, KK; Lee, VW; Leung, VY; Li, EK; Lim, PL; Tam, LS; Thomas, GN; Tomlinson, B; Whitney, B, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tam, LS1
Li, EK1
Leung, VY1
Griffith, JF1
Benzie, IF1
Lim, PL1
Whitney, B1
Lee, VW1
Lee, KK1
Thomas, GN1
Tomlinson, B1

Trials

1 trial available for allantoin and Libman-Sacks Disease

ArticleYear
Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    The Journal of rheumatology, 2005, Volume: 32, Issue:2

    Topics: Allantoin; Antioxidants; Ascorbic Acid; Biomarkers; Dietary Supplements; Double-Blind Method; Drug T

2005